350 related articles for article (PubMed ID: 27763790)
1. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
[TBL] [Abstract][Full Text] [Related]
2. Rapid on-site assessment of specimens by biomedical scientists improves the quality of head and neck fine needle aspiration cytology.
Breeze J; Poller DN; Gibson D; Tilley EA; Cooke L; Soar E; Repanos C
Cytopathology; 2014 Oct; 25(5):316-21. PubMed ID: 24138590
[TBL] [Abstract][Full Text] [Related]
3. Rapid on-site evaluation of fine needle aspiration specimens by cytology scientists: a review of 3032 specimens.
Shield PW; Cosier J; Ellerby G; Gartrell M; Papadimos D
Cytopathology; 2014 Oct; 25(5):322-9. PubMed ID: 24844295
[TBL] [Abstract][Full Text] [Related]
4. Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.
Schneider F; Smith MA; Lane MC; Pantanowitz L; Dacic S; Ohori NP
Am J Clin Pathol; 2015 Feb; 143(2):193-200; quiz 306. PubMed ID: 25596245
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling can predict adequacy rates and needle passes for fine needle aspiration cytology with rapid on-site evaluation.
Schmidt RL; Kordy MA
Cytopathology; 2015 Aug; 26(4):217-23. PubMed ID: 24975327
[TBL] [Abstract][Full Text] [Related]
7. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
[TBL] [Abstract][Full Text] [Related]
8. Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling.
Roy-Chowdhuri S; Mehrotra M; Bolivar AM; Kanagal-Shamanna R; Barkoh BA; Hannigan B; Zalles S; Ye W; Duose D; Broaddus R; Staerkel G; Wistuba I; Medeiros LJ; Luthra R
Mod Pathol; 2018 Jul; 31(7):1036-1045. PubMed ID: 29463880
[TBL] [Abstract][Full Text] [Related]
9. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
[TBL] [Abstract][Full Text] [Related]
10. Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.
Harada S; Agosto-Arroyo E; Levesque JA; Alston E; Janowski KM; Coshatt GM; Eltoum IA
Cancer Cytopathol; 2015 Aug; 123(8):480-7. PubMed ID: 25955105
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the collection approaches of 2 large thyroid fine-needle aspiration practices reveals differing advantages for cytology and molecular testing adequacy rates.
Landau MS; Pearce TM; Carty SE; Wolfe J; Yip L; McCoy KL; LeBeau SO; Tublin ME; Ohori NP
J Am Soc Cytopathol; 2019; 8(5):243-249. PubMed ID: 31543223
[TBL] [Abstract][Full Text] [Related]
12. Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
Rafael OC; Aziz M; Raftopoulos H; Vele OE; Xu W; Sugrue C
Cancer Cytopathol; 2014 Jun; 122(6):454-8. PubMed ID: 24723383
[TBL] [Abstract][Full Text] [Related]
13. Role of cytotechnologists in rapid onsite adequacy assessment of cytology materials for diagnostic workup and specimen allocation for ancillary testing using a standardized protocol.
Fetzer R; Duey M; Pena V; Wanzer D; Kirkpatrick J; Chau D; Sarode VR
J Am Soc Cytopathol; 2020; 9(2):67-75. PubMed ID: 31543473
[TBL] [Abstract][Full Text] [Related]
14. Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples.
Guerini-Rocco E; Passaro A; Casadio C; De Luca VM; Guarize J; de Marinis F; Vacirca D; Barberis M
Arch Pathol Lab Med; 2018 Apr; 142(4):465-473. PubMed ID: 29565206
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial cytology: Use of on-site evaluation of small biopsy and FNA samples for clinical trials and biomarker research studies.
Manzo JL; Cuda J; Pantanowitz L; Xing J; Yu J; Beasley HS; Dhir R; Monaco SE
Cancer Cytopathol; 2018 Jul; 126(7):. PubMed ID: 29719135
[TBL] [Abstract][Full Text] [Related]
16. The comparative effectiveness of fine-needle aspiration cytology sampling policies: a simulation study.
Schmidt RL; Howard K; Hall BJ; Layfield LJ
Am J Clin Pathol; 2012 Dec; 138(6):823-30. PubMed ID: 23161716
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions.
Han LM; Khanafshar E; Afshar AR; Calkins SM
Cancer Cytopathol; 2020 Jul; 128(7):499-505. PubMed ID: 32196967
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens.
Hannigan B; Ye W; Mehrotra M; Lam V; Bolivar A; Zalles S; Barkoh BA; Duose D; Hu PC; Broaddus R; Stewart J; Heymach J; Medeiros LJ; Wistuba I; Luthra R; Roy-Chowdhuri S
Ann Oncol; 2019 Jun; 30(6):963-969. PubMed ID: 30887015
[TBL] [Abstract][Full Text] [Related]
19. Molecular Testing of Non-Small Cell Lung Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Fine-Needle Aspiration: The Cleveland Clinic Experience.
Doxtader EE; Cheng YW; Zhang Y
Arch Pathol Lab Med; 2019 Jun; 143(6):670-676. PubMed ID: 29372844
[TBL] [Abstract][Full Text] [Related]
20. Test Feasibility of Next-Generation Sequencing Assays in Clinical Mutation Detection of Small Biopsy and Fine Needle Aspiration Specimens.
Zheng G; Tsai H; Tseng LH; Illei P; Gocke CD; Eshleman JR; Netto G; Lin MT
Am J Clin Pathol; 2016 May; 145(5):696-702. PubMed ID: 27247373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
